It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 | Mumbai, Maharashtra, India | ActiveSulabh Pharmaceutical Private Limited, a active private limited company, was established on 14 March 2012 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101MH2012PTC228079. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.24 M.
It upholds a compliant status. Its leadership includes Anita Pravinbhai Prajapati (Director), Pravinkumar Narayanbhai Prajapati (Director). Past directors included Narayanbhai Mohanlal Prajapati, Ashwin Mangaldas Pandya. It holds ₹12.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 102, Royal Appartment, Kasam Baug, Opp. Bachani Nagar, Jai Bhavani Lane, Ma, Lad (E), Mumbai, Maharashtra, 400097.
U51101MH2012PTC228079
228079
14 March 2012
₹5.00 Cr
₹5.24 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sulabh Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anita Pravinbhai Prajapati | Director | 14 Mar 2012 | Current |
| Pravinkumar Narayanbhai Prajapati | Director | 14 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 05 Oct 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sulabh Pharmaceutical Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 1.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 123.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sulabh Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹120,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2016 | Others | ₹12.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sulabh Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sulabh Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sulabh Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sulabh Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
The activity Sulabh Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Progress on A charge with Others of Rs. 12.00 Cr registered on 07 Oct 2016 with Charge ID 100067403 was modified on 08 Feb 2018. was documented.
Progress on A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100067403 was registered on 07 Oct 2016. was documented.
Anita Pravinbhai Prajapati was appointed as a Director was appointed as a Director on 14 Mar 2012 & has been associated with this company since 13 years 8 months . was recorded as a recent event.
The activity Pravinkumar Narayanbhai Prajapati was appointed as a Director was appointed as a Director on 14 Mar 2012 & has been associated with this company since 13 years 8 months . was completed.
The CIN of Sulabh Pharmaceutical Private Limited is U51101MH2012PTC228079.
Sulabh Pharmaceutical Private Limited is headquartered at 102, Royal Appartment, Kasam Baug, Opp. Bachani Nagar, Jai Bhavani Lane, Ma, Lad (E), Mumbai, Maharashtra, 400097.
Sulabh Pharmaceutical Private Limited was incorporated on 14 March 2012.
The current directors of Sulabh Pharmaceutical Private Limited are
The primary industry of Sulabh Pharmaceutical Private Limited is Trade.
Sulabh Pharmaceutical Private Limited is unlisted.
The authorized capital of Sulabh Pharmaceutical Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.24 M.
The compliance status of Sulabh Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX